Literature DB >> 24412695

Comparison of paired serum and lithium heparin plasma samples for the measurement of serum amyloid A in horses using an automated turbidimetric immunoassay.

Judith Howard1, Claudia Graubner2.   

Abstract

This study aimed to evaluate whether equine serum amyloid A (SAA) concentrations could be reliably measured in plasma with a turbidimetric immunoassay previously validated for equine SAA concentrations in serum. Paired serum and lithium-heparin samples obtained from 40 horses were evaluated. No difference was found in SAA concentrations between serum and plasma using a paired t test (P=0.48). The correlation between paired samples was 0.97 (Spearman's rank P<0.0001; 95% confidence interval 0.95-0.99). Passing-Bablok regression analyses revealed no differences between paired samples. Bland-Altman plots revealed a positive bias in plasma compared to serum but the difference was not considered clinically significant. The results indicate that lithium-heparin plasma samples are suitable for measurement of equine SAA using this method. Use of either serum or plasma allows for greater flexibility when it comes to sample collection although care should be taken when comparing data between measurements from different sample types.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Acute phase proteins; Anticoagulant effects; Horse; Plasma; Serum amyloid A

Mesh:

Substances:

Year:  2013        PMID: 24412695     DOI: 10.1016/j.tvjl.2013.12.007

Source DB:  PubMed          Journal:  Vet J        ISSN: 1090-0233            Impact factor:   2.688


  2 in total

1.  Serum amyloid A and plasma protein electrophoresis fractions in farmed white-tailed deer.

Authors:  Carolyn Cray; Roxanne I Knibb; Jeffrey R Knibb
Journal:  J Vet Diagn Invest       Date:  2019-03-11       Impact factor: 1.279

Review 2.  Equine Inflammatory Markers in the Twenty-First Century: A Focus on Serum Amyloid A.

Authors:  Alicia Long; Rose Nolen-Walston
Journal:  Vet Clin North Am Equine Pract       Date:  2020-01-30       Impact factor: 1.792

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.